38540164|t|Hyperchloremia and Hypernatremia Decreased Microglial and Neuronal Survival during Oxygen-Glucose Deprivation/Reperfusion.
38540164|a|Hyperchloremia and hypernatremia are associated with higher mortality in ischemic stroke, but it remains unclear whether their influence directly contributes to ischemic injury. We investigated the impact of 0.9% sodium chloride (154 mM NaCl), 0.9% sodium acetate (167 mM CH3COONa), and their different combinations (3:1, 2:1, and 1:1) on microglial (HMC-3) and neuronal (differentiated SH-SY5Y) survival during oxygen-glucose deprivation/reperfusion (OGD/R). Further, we assessed the effect of hyperchloremia and hypernatremia-treated and OGD/R-induced HMC-3-conditioned media on differentiated SH-SY5Y cells under OGD/R conditions. We performed cell viability, cell toxicity, and nitric oxide (NO) release assays and studied the alteration in expression of caspase-1 and caspase-3 in different cell lines when exposed to hyperchloremia and hypernatremia. Cell survival was decreased in 0.9% NaCl, 0.9% CH3COONa, combinations of HMC-3 and differentiated SH-SY5Y, and differentiated SH-SY5Y cells challenged with HMC-3-conditioned media under normal and OGD/R conditions. Under OGD/R conditions, differentiated SH-SY5Y cells were less likely to survive exposure to 0.9% NaCl. Expression of caspase-1 and caspase-3 in HMC-3 and differentiated SH-SY5Y cells was altered when exposed to 0.9% NaCl, 0.9% CH3COONa, and their combinations. A total of 0.9% NaCl and 0.9% CH3COONa and their combinations decreased the NO production in HMC-3 cells under normal and OGD/R conditions. Both hypernatremia and hyperchloremia reduced the survival of HMC-3 and differentiated SH-SY5Y cells under OGD/R conditions. Based on the OGD/R in vitro model that mimics human ischemic stroke conditions, it possibly provides a link for the increased death associated with hyperchloremia or hypernatremia in stroke patients.
38540164	0	14	Hyperchloremia	Disease	
38540164	19	32	Hypernatremia	Disease	MESH:D006955
38540164	83	89	Oxygen	Chemical	MESH:D010100
38540164	90	97	Glucose	Chemical	MESH:D005947
38540164	123	137	Hyperchloremia	Disease	
38540164	142	155	hypernatremia	Disease	MESH:D006955
38540164	196	211	ischemic stroke	Disease	MESH:D002544
38540164	284	299	ischemic injury	Disease	MESH:D017202
38540164	336	351	sodium chloride	Chemical	MESH:D012965
38540164	360	364	NaCl	Chemical	MESH:D012965
38540164	372	386	sodium acetate	Chemical	MESH:D019346
38540164	395	403	CH3COONa	Chemical	-
38540164	474	479	HMC-3	CellLine	CVCL:II76
38540164	510	517	SH-SY5Y	CellLine	CVCL:0019
38540164	535	541	oxygen	Chemical	MESH:D010100
38540164	542	549	glucose	Chemical	MESH:D005947
38540164	575	578	OGD	Disease	MESH:C536050
38540164	618	632	hyperchloremia	Disease	
38540164	637	650	hypernatremia	Disease	MESH:D006955
38540164	663	666	OGD	Disease	MESH:C536050
38540164	677	682	HMC-3	CellLine	CVCL:II76
38540164	719	726	SH-SY5Y	CellLine	CVCL:0019
38540164	739	742	OGD	Disease	MESH:C536050
38540164	791	799	toxicity	Disease	MESH:D064420
38540164	805	817	nitric oxide	Chemical	MESH:D009569
38540164	819	821	NO	Chemical	MESH:D009569
38540164	882	891	caspase-1	Gene	834
38540164	896	905	caspase-3	Gene	836
38540164	946	960	hyperchloremia	Disease	
38540164	965	978	hypernatremia	Disease	MESH:D006955
38540164	1016	1020	NaCl	Chemical	MESH:D012965
38540164	1027	1035	CH3COONa	Chemical	-
38540164	1053	1058	HMC-3	CellLine	CVCL:II76
38540164	1078	1085	SH-SY5Y	CellLine	CVCL:0019
38540164	1106	1113	SH-SY5Y	CellLine	CVCL:0019
38540164	1136	1141	HMC-3	CellLine	CVCL:II76
38540164	1177	1180	OGD	Disease	MESH:C536050
38540164	1201	1204	OGD	Disease	MESH:C536050
38540164	1234	1241	SH-SY5Y	CellLine	CVCL:0019
38540164	1293	1297	NaCl	Chemical	MESH:D012965
38540164	1313	1322	caspase-1	Gene	834
38540164	1327	1336	caspase-3	Gene	836
38540164	1340	1345	HMC-3	CellLine	CVCL:II76
38540164	1365	1372	SH-SY5Y	CellLine	CVCL:0019
38540164	1412	1416	NaCl	Chemical	MESH:D012965
38540164	1423	1431	CH3COONa	Chemical	-
38540164	1473	1477	NaCl	Chemical	MESH:D012965
38540164	1487	1495	CH3COONa	Chemical	-
38540164	1533	1535	NO	Chemical	MESH:D009569
38540164	1550	1555	HMC-3	CellLine	CVCL:II76
38540164	1579	1582	OGD	Disease	MESH:C536050
38540164	1602	1615	hypernatremia	Disease	MESH:D006955
38540164	1620	1634	hyperchloremia	Disease	
38540164	1659	1664	HMC-3	CellLine	CVCL:II76
38540164	1684	1691	SH-SY5Y	CellLine	CVCL:0019
38540164	1704	1707	OGD	Disease	MESH:C536050
38540164	1735	1738	OGD	CellLine	
38540164	1739	1740	R	Disease	MESH:C580424
38540164	1768	1773	human	Species	9606
38540164	1774	1789	ischemic stroke	Disease	MESH:D002544
38540164	1870	1884	hyperchloremia	Disease	
38540164	1888	1901	hypernatremia	Disease	MESH:D006955
38540164	1905	1911	stroke	Disease	MESH:D020521
38540164	1912	1920	patients	Species	9606
38540164	Association	MESH:D006955	834
38540164	Negative_Correlation	MESH:D009569	MESH:D012965
38540164	Association	MESH:D012965	836
38540164	Association	MESH:D012965	834
38540164	Association	MESH:D006955	836

